• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫印迹:快速进化病毒的初次抗原接触的持续影响。

Immune imprinting: The persisting influence of the first antigenic encounter with rapidly evolving viruses.

机构信息

Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada.

School of Epidemiology and Public Health, University of Ottawa Faculty of Medicine, Ottawa, ON, Canada.

出版信息

Hum Vaccin Immunother. 2024 Dec 31;20(1):2384192. doi: 10.1080/21645515.2024.2384192. Epub 2024 Aug 16.

DOI:10.1080/21645515.2024.2384192
PMID:39149872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11328881/
Abstract

Immune imprinting is a phenomenon that stems from the fundamentals of immunological memory. Upon recurrent exposures to an evolving pathogen, the immune system must weigh the benefits of rapidly recalling established antibody repertoires with greater affinity to the initial variant or invest additional time and energy in producing responses specific to the emerging variant. In this review, we delve into the mechanistic complexities of immune imprinting and its role in shaping subsequent immune responses, both and recall, against rapidly evolving respiratory viruses such as influenza and coronaviruses. By exploring the duality of immune imprinting, we examine its potential to both enhance or hinder immune protection against disease, while emphasizing the role of host and viral factors. Finally, we explore how different vaccine platforms may affect immune imprinting and comment on vaccine strategies that can favor variant-specific antibody responses.

摘要

免疫印迹是一种源自免疫记忆基本原理的现象。当反复暴露于不断进化的病原体时,免疫系统必须权衡快速回忆具有更高亲和力的初始变体的既定抗体库的好处,还是投入更多时间和精力产生针对新兴变体的特异性反应。在这篇综述中,我们深入探讨了免疫印迹的机制复杂性及其在塑造对流感和冠状病毒等快速进化的呼吸道病毒的后续免疫反应(包括初次和回忆反应)中的作用。通过探索免疫印迹的双重性,我们研究了它增强或阻碍针对疾病的免疫保护的潜力,同时强调宿主和病毒因素的作用。最后,我们探讨了不同的疫苗平台如何影响免疫印迹,并对有利于特定变异体抗体反应的疫苗策略进行了评论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd2/11328881/61e22adc20e6/KHVI_A_2384192_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd2/11328881/24dc8c5d42b6/KHVI_A_2384192_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd2/11328881/61e22adc20e6/KHVI_A_2384192_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd2/11328881/24dc8c5d42b6/KHVI_A_2384192_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd2/11328881/61e22adc20e6/KHVI_A_2384192_F0002_OC.jpg

相似文献

1
Immune imprinting: The persisting influence of the first antigenic encounter with rapidly evolving viruses.免疫印迹:快速进化病毒的初次抗原接触的持续影响。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2384192. doi: 10.1080/21645515.2024.2384192. Epub 2024 Aug 16.
2
Vaccination against rapidly evolving pathogens and the entanglements of memory.针对快速进化病原体的疫苗接种和记忆的纠缠。
Nat Immunol. 2024 Nov;25(11):2015-2023. doi: 10.1038/s41590-024-01970-2. Epub 2024 Oct 9.
3
Differential antigenic imprinting effects between influenza H1N1 hemagglutinin and neuraminidase in a mouse model.小鼠模型中甲型H1N1流感病毒血凝素与神经氨酸酶之间的差异抗原印记效应
J Virol. 2025 Jan 31;99(1):e0169524. doi: 10.1128/jvi.01695-24. Epub 2024 Dec 5.
4
First Impressions Matter: Immune Imprinting and Antibody Cross-Reactivity in Influenza and SARS-CoV-2.第一印象很重要:流感和新冠病毒中的免疫印记与抗体交叉反应性
Pathogens. 2023 Jan 21;12(2):169. doi: 10.3390/pathogens12020169.
5
Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults.流感病毒感染可诱导儿童产生狭窄的抗体反应,但可诱导成人产生广泛的回忆反应。
mBio. 2020 Jan 21;11(1):e03243-19. doi: 10.1128/mBio.03243-19.
6
Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin.接种疫苗会损害针对奥密克戎突破性感染的新免疫反应,这是原始抗原性错误的前提条件。
Nat Commun. 2024 Apr 10;15(1):3102. doi: 10.1038/s41467-024-47451-w.
7
B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat.B 细胞对流感病毒的反应:针对终身威胁的短暂体液免疫。
Viruses. 2021 May 22;13(6):965. doi: 10.3390/v13060965.
8
Imprinted Anti-Hemagglutinin and Anti-Neuraminidase Antibody Responses after Childhood Infections of A(H1N1) and A(H1N1)pdm09 Influenza Viruses.儿童感染 A(H1N1)和 A(H1N1)pdm09 流感病毒后的抗血凝素和抗神经氨酸酶抗体反应。
mBio. 2023 Jun 27;14(3):e0008423. doi: 10.1128/mbio.00084-23. Epub 2023 Apr 18.
9
Mapping the Antibody Repertoires in Ferrets with Repeated Influenza A/H3 Infections: Is Original Antigenic Sin Really "Sinful"?重复感染甲型流感病毒 A/H3 对雪貂抗体库进行映射:原始抗原性错误真的“有罪”吗?
Viruses. 2023 Jan 28;15(2):374. doi: 10.3390/v15020374.
10
Infant Antibody Repertoires during the First Two Years of Influenza Vaccination.婴儿在接种流感疫苗后的头两年中的抗体库。
mBio. 2022 Dec 20;13(6):e0254622. doi: 10.1128/mbio.02546-22. Epub 2022 Oct 31.

引用本文的文献

1
Factors determining the outcomes of immune imprinting after repeated orthoflavivirus infections.决定反复感染黄病毒属病毒后免疫印记结果的因素。
Front Immunol. 2025 Jul 16;16:1560851. doi: 10.3389/fimmu.2025.1560851. eCollection 2025.
2
Monitoring of antibodies against SARS-CoV-2 over 2 years and characterization of immune responses following Omicron infection in a South Indian community cohort.在南印度一个社区队列中对2年期间抗SARS-CoV-2抗体的监测以及奥密克戎感染后免疫反应的特征分析。
Sci Rep. 2025 Jul 9;15(1):24756. doi: 10.1038/s41598-025-10447-7.
3
A 22 month prospective assessment of neutralizing and IgG antibody levels against SARS-CoV-2 variants following homologous and heterologous BNT162b2 boosting.

本文引用的文献

1
Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model.在母源抗体小鼠模型中评估mRNA-LNP和佐剂蛋白SARS-CoV-2疫苗。
NPJ Vaccines. 2024 Jun 18;9(1):110. doi: 10.1038/s41541-024-00901-4.
2
Opposing effects of pre-existing antibody and memory T cell help on the dynamics of recall germinal centers.预先存在的抗体和记忆 T 细胞辅助对回忆生发中心动态的相反影响。
Immunity. 2024 Jul 9;57(7):1618-1628.e4. doi: 10.1016/j.immuni.2024.05.009. Epub 2024 Jun 4.
3
B-cell characteristics define HCV reinfection outcome.
同源和异源BNT162b2加强免疫后针对SARS-CoV-2变异株的中和抗体和IgG抗体水平的22个月前瞻性评估。
Sci Rep. 2025 Jul 1;15(1):21175. doi: 10.1038/s41598-025-05377-3.
4
Mucosal boosting increases protective efficacy of an influenza vaccine in mice.黏膜加强免疫可提高流感疫苗对小鼠的保护效力。
iScience. 2025 May 21;28(6):112721. doi: 10.1016/j.isci.2025.112721. eCollection 2025 Jun 20.
5
Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern.后疫情时代:SARS-CoV-2疫苗针对新出现的关注变异株的最新进展与效果
Vaccines (Basel). 2025 Apr 17;13(4):424. doi: 10.3390/vaccines13040424.
6
Systemic and Mucosal Antibody Responses to SARS-CoV-2 Variant-Specific Prime-and-Boost and Prime-and-Spike Vaccination: A Comparison of Intramuscular and Intranasal Bivalent Vaccine Administration in a Murine Model.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株特异性初免-加强和初免-刺突蛋白疫苗接种的全身和黏膜抗体反应:小鼠模型中肌肉注射和鼻内二价疫苗接种的比较
Vaccines (Basel). 2025 Mar 25;13(4):351. doi: 10.3390/vaccines13040351.
7
Virus-Induced Pathogenic Antibodies: Lessons from Long COVID and Dengue Hemorrhage Fever.病毒诱导的致病性抗体:来自长期新冠和登革出血热的教训。
Int J Mol Sci. 2025 Feb 22;26(5):1898. doi: 10.3390/ijms26051898.
8
Antigenic Imprinting Dominates Humoral Responses to New Variants of SARS-CoV-2 in a Hamster Model of COVID-19.在新冠病毒仓鼠模型中,抗原印记主导了对新冠病毒新变种的体液免疫反应。
Microorganisms. 2024 Dec 14;12(12):2591. doi: 10.3390/microorganisms12122591.
9
A polygeneric immunogen composed of 22 venoms from sub-Saharan African snakes to expand the neutralization scope of the EchiTAb-plus-ICP antivenom.一种由22种撒哈拉以南非洲蛇类毒液组成的多属免疫原,用于扩大EchiTAb-plus-ICP抗蛇毒血清的中和范围。
Toxicon X. 2024 Nov 16;24:100213. doi: 10.1016/j.toxcx.2024.100213. eCollection 2024 Dec.
10
Contribution of immunoglobulin products in influencing seasonal influenza infection and severity in antibody immune deficiency patients receiving immunoglobulin replacement therapy.免疫球蛋白制品对接受免疫球蛋白替代治疗的抗体免疫缺陷患者季节性流感感染和严重程度的影响。
Front Immunol. 2024 Oct 22;15:1452106. doi: 10.3389/fimmu.2024.1452106. eCollection 2024.
B 细胞特征决定 HCV 再感染结局。
J Hepatol. 2024 Sep;81(3):415-428. doi: 10.1016/j.jhep.2024.04.004. Epub 2024 Apr 10.
4
Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants.免疫印迹塑造了人类针对 SARS-CoV-2 变体的抗体反应特异性。
Immunity. 2024 Apr 9;57(4):912-925.e4. doi: 10.1016/j.immuni.2024.02.017. Epub 2024 Mar 14.
5
Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans.接种 COVID-19 XBB.1.5 mRNA 加强针后,人体会持续产生免疫印记。
Immunity. 2024 Apr 9;57(4):904-911.e4. doi: 10.1016/j.immuni.2024.02.016. Epub 2024 Mar 14.
6
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1.XBB.1.5 单价 mRNA 疫苗加强针可诱导针对 XBB 亚谱系和 JN.1 的强大中和抗体。
Cell Host Microbe. 2024 Mar 13;32(3):315-321.e3. doi: 10.1016/j.chom.2024.01.014. Epub 2024 Feb 19.
7
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting.多次感染奥密克戎会颠覆原始 SARS-CoV-2 免疫印记。
Nature. 2024 Jan;625(7993):148-156. doi: 10.1038/s41586-023-06753-7. Epub 2023 Nov 22.
8
Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell pool.突破性感染后增强的 SARS-CoV-2 体液免疫建立在预先存在的记忆 B 细胞库之上。
Sci Immunol. 2023 Nov 17;8(89):eadk5845. doi: 10.1126/sciimmunol.adk5845.
9
Immune imprinting and next-generation coronavirus vaccines.免疫印记与下一代冠状病毒疫苗。
Nat Microbiol. 2023 Nov;8(11):1971-1985. doi: 10.1038/s41564-023-01505-9. Epub 2023 Nov 6.
10
SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster.第二次BA.5二价加强针后的新型冠状病毒2型中和抗体
Lancet. 2023 Nov 18;402(10415):1827-1828. doi: 10.1016/S0140-6736(23)02278-X. Epub 2023 Oct 31.